Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rilei Yu

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|December 3, 2025
Dual-Action Tetrapeptide Analogue of Psychrophilic Fungal Origin: Potent Inhibitor of Human Nicotinic Acetylcholine Receptors with Antinociceptive and Muscle-Relaxant ActivityLu Lu, Han-Shen Tae, Cheng Ge, et al.
Journal of Medicinal Chemistry|May 25, 2026
Correction to "Discovery of Imidazo[2,1-<i>b</i>][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB Signaling"Hongwei Li, Huiying Zhuang, Dianxi Zhang, et al.
Food Chemistry|May 23, 2024
Unraveling novel umami peptides from yeast extract (Saccharomyces cerevisiae) using peptidomics and molecular interaction modelingChunyu Gao, Rilei Yu, Xiaomei Zhang, et al.
Journal of Medicinal Chemistry|April 7, 2026
Discovery of Imidazo[2,1-<i>b</i>][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB SignalingHongwei Li, Huiying Zhuang, Dianxi Zhang, et al.
Journal of Medicinal Chemistry|June 26, 2026
Structure-Guided Optimization of α-Conotoxins Yields Potent and Selective Inhibitors of the Human α6β4 nAChR for Nicotine AddictionZhengji Yin, Linhong Huang, Zhongdong Yang, et al.
Marine Drugs|August 25, 2022
Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine ReceptorYuan Ma, Qiushi Cao, Mengke Yang, et al.
Nature Communications|April 2, 2025
Molecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognitionJiawei Su, Zhuoya Yu, Zhengji Yin, et al.
Journal of Medicinal Chemistry|October 24, 2024
Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic PainTianmiao Li, Han-Shen Tae, Shen Chen, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 21, 2020
Exploring the Antihyperglycemic Chemical Composition and Mechanisms of Tea Using Molecular DockingYue Sun, Lufei Wang, Lily K Shaughnessy, et al.
Journal of Medicinal Chemistry|June 11, 2020
Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane FusionGuangwei Wu, Guihong Yu, Yunjia Yu, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|December 3, 2025
Dual-Action Tetrapeptide Analogue of Psychrophilic Fungal Origin: Potent Inhibitor of Human Nicotinic Acetylcholine Receptors with Antinociceptive and Muscle-Relaxant ActivityLu Lu, Han-Shen Tae, Cheng Ge, et al.
Journal of Medicinal Chemistry|May 25, 2026
Correction to "Discovery of Imidazo[2,1-<i>b</i>][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB Signaling"Hongwei Li, Huiying Zhuang, Dianxi Zhang, et al.
Food Chemistry|May 23, 2024
Unraveling novel umami peptides from yeast extract (Saccharomyces cerevisiae) using peptidomics and molecular interaction modelingChunyu Gao, Rilei Yu, Xiaomei Zhang, et al.
Journal of Medicinal Chemistry|April 7, 2026
Discovery of Imidazo[2,1-<i>b</i>][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB SignalingHongwei Li, Huiying Zhuang, Dianxi Zhang, et al.
Journal of Medicinal Chemistry|June 26, 2026
Structure-Guided Optimization of α-Conotoxins Yields Potent and Selective Inhibitors of the Human α6β4 nAChR for Nicotine AddictionZhengji Yin, Linhong Huang, Zhongdong Yang, et al.
Marine Drugs|August 25, 2022
Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine ReceptorYuan Ma, Qiushi Cao, Mengke Yang, et al.
Nature Communications|April 2, 2025
Molecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognitionJiawei Su, Zhuoya Yu, Zhengji Yin, et al.
Journal of Medicinal Chemistry|October 24, 2024
Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic PainTianmiao Li, Han-Shen Tae, Shen Chen, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 21, 2020
Exploring the Antihyperglycemic Chemical Composition and Mechanisms of Tea Using Molecular DockingYue Sun, Lufei Wang, Lily K Shaughnessy, et al.
Journal of Medicinal Chemistry|June 11, 2020
Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane FusionGuangwei Wu, Guihong Yu, Yunjia Yu, et al.
Pageof 13